Monday, September 17, 2012    |    |    Archives    |   Advertising   |    CHI Conferences    |     Subscribe       


Mathieu Takeaways on the 2012 Clinical Trial Sourcebook
eCliniqua | Mark Mathieu—director of Strategic Research at PAREXEL Consulting—is the founding editor of the PAREXEL Biopharmaceutical R&D Statistical
Sourcebook. As such, he is the ideal person to discuss the highlights and nuances that emerge in the latest edition of the sourcebook (2012-13). Mathieu
recently spoke to Barnett International’s Rachel Meyers.  

Isis Tightens Bond to BioClinica
eCliniqua Exclusive | EDC purist Isis Pharmaceuticals is stepping up its partnering activity with BioClinica, Inc. to include larger and more complex clinical
trials within its expansive antisense drug development program. Up to 20 new trials are on the docket for next year, including several phase III studies involving
thousands of participants. 

Are You Ready for Vendor Oversight Scrutiny?
Guest Commentary | Regulators are paying increased attention to sponsors within the realm of vendor oversight. Clinical Trial Sponsors must include vendor
oversight in any assessment of inspection readiness on their mid-stage development programs, and once the gaps have been identified, apply preventative
actions across all outsourced programs in development. 

Department of Health and Human Services Launches Trial Research with Medidata Databases
eCliniqua | The U.S. Department of Health and Human Services (HHS) has chosen Medidata’s trial cost benchmark data to support research into current cost
data for clinical trials. 

NextDocs Launches Trial Exchange
Product Brief | NextDocs Corporation has launched Trial Exchange, a simple, consumer-style interface for investigators and site staff to access and contribute
essential documents for clinical trials.   

PHT Corporation Announces NetPRO 1.3 for Patient Data Capture
eCliniqua | PHT Corporation has released NetPRO 1.3, the latest version of its web-based system for collecting patient and clinician data for clinical trials and
post-marketing studies.   


CDISC and C-Path Launch Coalition for Accelerating Standards Therapies
CDISC | The Clinical Data Interchange Standards Consortium (CDISC) and Critical Path Institute (C-Path) have announced the launch of the Coalition For
Accelerating Standards and Therapies (CFAST), a follow-up to the partnership agreement signed earlier this year.  
Read More

Informed Consent: There's an App for That
PharmaTimes | Mytrus has launched an iPad app explaining the informed consent process.   Read More

Technology to Replace Doctors?
VB | Vinod Khosla, co-founder of Sun Microsytems, says technology will replace 80% of doctors.   Read More

More Choice in British Clinical IT Systems
Onmedica | IT supplier CSC has lost its exclusive rights to be the only provider of clinical IT systems in the North, Midlands and East of England.   Read More

GUEST COMMENTARY: Can Outsourcing Reach Its Full Potential?
eCliniqua | GUEST COMMENTARY | Faced with a looming patent cliff, supply-chain issues and dwindling pipelines, Big Pharma has to take a closer look at
outsourcing as a way to bolster development and manufacturing strategies. Electing for a leaner approach makes sense for many reasons but several key
concerns must be addressed, ranging from innovation to emerging markets. 
Read More